Cited by

• Low Virulence and Lack of Airborne Transmission of the Dutch Highly Pathogenic Avian Influenza Virus H5N8 in Ferrets.

  Richard M, Herfst S, van den Brand JM, Lexmond P, Bestebroer TM, Rimmelzwaan GF, Koopmans M, Kuiken T, Fouchier RA. Richard M, et al. PLoS One. 2015 Jun 19;10(6):e0129827. doi: 10.1371/journal.pone.0129827. eCollection 2015. PLoS One. 2015. PMID: 26090682 Free PMC article.
• Distinct Host Tropism Protein Signatures to Identify Possible Zoonotic Influenza A Viruses.

  Eng CL, Tong JC, Tan TW. Eng CL, et al. PLoS One. 2016 Feb 25;11(2):e0150173. doi: 10.1371/journal.pone.0150173. eCollection 2016. PLoS One. 2016. PMID: 26915079 Free PMC article.
• Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses.

  Chen LM, Donis RO, Suarez DL, Wentworth DE, Webby R, Engelhardt OG, Swayne DE. Chen LM, et al. Influenza Other Respir Viruses. 2020 Mar;14(2):215-225. doi: 10.1111/irv.12698. Epub 2019 Oct 28. Influenza Other Respir Viruses. 2020. PMID: 31659871 Free PMC article. Review.
• Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection.

  Zhou F, Hansen L, Pedersen G, Grødeland G, Cox R. Zhou F, et al. Front Immunol. 2021 Nov 23;12:747774. doi: 10.3389/fimmu.2021.747774. eCollection 2021. Front Immunol. 2021. PMID: 34887855 Free PMC article. Clinical Trial.
• Avian influenza A (H5N1) infection with respiratory failure and meningoencephalitis in a Canadian traveller.

  Rajabali N, Lim T, Sokolowski C, Prevost JD, Lee EZ. Rajabali N, et al. Can J Infect Dis Med Microbiol. 2015 Jul-Aug;26(4):221-3. doi: 10.1155/2015/961080. Can J Infect Dis Med Microbiol. 2015. PMID: 26361492 Free PMC article.